Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance
en-GBde-DEes-ESfr-FR

Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance

15/05/2025 Compuscript Ltd

https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0083
Announcing a new publication for Acta Materia Medica journal. Tumor ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has emerged as a promising therapeutic strategy for combating cancers, particularly in cases involving cancer stem cells (CSCs) and drug resistance. In recent years nanomaterial-based approaches have gained significant attention for the potential to selectively induce ferroptosis in cancer cells while sparing normal tissues. This review article aims to provide a comprehensive overview of the current state-of-the-art in utilizing nanomaterials for targeting tumor ferroptosis with a specific focus on the application in eradicating CSCs and overcoming drug resistance mechanisms. The molecular mechanisms underlying ferroptosis induction by nanomaterials, the unique properties and functionalities of various nanomaterial platforms, and strategies for targeting CSCs and overcoming drug resistance using nanoferroptosis approaches are discussed. In addition, the preclinical and clinical evidence supporting the efficacy of nanomaterial platforms are evaluated. Furthermore, the challenges and future perspectives in the development and translation of nanoferroptosis-based therapies for precision cancer treatment are highlighted.
# # # # # #
Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
Submission Process
Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed
Queries about the journal can be sent to editorialoffice@amm-journal.org.
Please visit https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
There are no author submission or article processing fees.

Follow Acta Materia Medica on Twitter https://twitter.com/AMM_journal; Facebook (https://www.facebook.com/AMMjournal)
eISSN 2737-7946
# # # # # #
Xiaoman Wang, Jing Luo and Xuemei Zeng et al. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance. Acta Materia Medica. 2025. Vol. 4(3):358-389. DOI: 10.15212/AMM-2024-0083
Xiaoman Wang, Jing Luo and Xuemei Zeng et al. Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance. Acta Materia Medica. 2025. Vol. 4(3):358-389. DOI: 10.15212/AMM-2024-0083
15/05/2025 Compuscript Ltd
Regions: Europe, Ireland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement